Cerenome (CNSY) EBITDA Margin (2011 - 2026)
Cerenome's EBITDA Margin was -2170.32% in Q2 2026, down 2065.21 percentage points from -105.11% a year earlier and down 1487.15 percentage points from the prior quarter.
Cerenome (CNSY) EBITDA Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cerenome's EBITDA Margin was -617.30% through Jun 30, 2026, down 391.55 percentage points year-over-year; for FY2025, it came in at -284.92%, down 47.58 percentage points from FY2024.
- EBITDA Margin shows a three-year change of +8238.74 percentage points (FY2022 to FY2025).
- In earlier years, EBITDA Margin was -237.35% in FY2024 (+21.01 pp), -258.36% in FY2023 (+8265.31 pp) and -8523.66% in FY2022.
- The Q2 2026 figure marks the lowest quarterly EBITDA Margin since Q4 2022.
- Compared with a year earlier, EBITDA Margin has declined for four straight quarters, with an average year-over-year change of -345.30 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 6691.37 percentage points); the worst was Q2 2026 (a drop of 2065.21 percentage points).
- Per Business Quant data, CNSY's EBITDA Margin in the three quarters before Q2 2026 was -683.17% (Q1 2026), -409.44% (Q4 2025) and -315.32% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 39.16% |
| 10 | Cerenome | 11.59 Mn | -35.59 Mn | - | -2,170.32% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,170.32% |
| Mar 31, 2026 | -683.17% |
| Dec 31, 2025 | -409.44% |
| Sep 30, 2025 | -315.32% |
| Jun 30, 2025 | -105.11% |
| Mar 31, 2025 | -320.11% |
| Dec 31, 2024 | -251.56% |
| Sep 30, 2024 | -247.25% |
| Jun 30, 2024 | -275.45% |
| Mar 31, 2024 | -186.52% |
| Dec 31, 2023 | -280.05% |
| Sep 30, 2023 | -69.34% |
| Jun 30, 2023 | -67.21% |
| Mar 31, 2023 | -888.93% |
| Dec 31, 2022 | -3,531.79% |
| Sep 30, 2022 | -6,636.99% |
| Mar 31, 2019 | -221.19% |
| Dec 31, 2018 | -82.70% |
| Sep 30, 2018 | -182.52% |
| Jun 30, 2018 | -191.06% |
Cerenome EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNSY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CNSY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CNSY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();